Recent Advances in Japanese Encephalitis

References

• Anderson JF, Rahal JJ (2002). Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 8: 107–108.
   PubMed Web of Science ®Google Scholar
• Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ (2001). Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese en-cephalitis virus chimera vaccine (ChimeriVax-JE).J Virol 75: 934–942.
   Google Scholar
• Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA (2000). The West Nile virus outbreak of 1999 inNew York: the Flushing Hospital experience. Clin Infect Dis 30: 413–418.
   PubMed Web of Science ®Google Scholar
• Burke DS, Morrill JC (1987). Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J Infect Dis 155: 797–799.
   Google Scholar
• Cecilia D, Gould EA (1991). Nucleotide changes respsonsi-ble for loss of neuroinvasiveness in Japanese encephali-tis virus neutralisation-resistant mice. Virology 181: 70–77.
   PubMed Web of Science ®Google Scholar
• Chambers TJ, Hahn CS, Galler R, Rice CM (1990). Flavivirus genome organisation, expression and replication. Annu Rev Microbic)] 44: 649–688.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Raung SL, Kuo MD, Wang YM (2002). Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J Gen Virol 83: 1897–1905.
   Google Scholar
• Chen WR, Ricco-Hesse R, Tesh RB (1992). A new genotype of Japanese virus from Indonesia. Am J Trop Med Hyg 47: 61–69.
   PubMed Web of Science ®Google Scholar
• Chen WR, Tesh RB, Ricco-Hesse R (1990). Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 71: 2915–2922.
   PubMed Web of Science ®Google Scholar
• Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM (1997). Dengue virus infectiv-ity depends on envelope protein binding to target cell heparan sulphate. Nat Med 3: 866–871.
   PubMed Web of Science ®Google Scholar
• Chiou SS, Chen WJ (2001). Mutations in the N53 gene and 3'-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus. Virology 289: 129–136.
   Google Scholar
• Despres P, Frenkiel MP, Ceccaldi PE, Duarte Dos Santos C, Deubel V (1998). Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol 72: 823–829.
   Google Scholar
• Ferlenghi I, Clarke M, Ruttan T, Allison SL, Schalich J, Heinz FX, Harrison SC, Rey FA, Fuller SD (2001). Molec-ular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell 7: 593–602.
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Pugachev K, Arroyo J, Miller C, Zhang ZX, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Draper K, Monath TP (2002). Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjust-ment, and antibody responses against wild-type dengue virus isolates. Virology 298: 146–159.
   PubMed Web of Science ®Google Scholar
• Harinasuta C, Nimmanitya S, Titsyakorn U (1985). The ef-fect of interferon alpha on two cases of Japanese en-cephalitis in Thailand. Southeast Asian J Trop Med Pub Health 16: 332–336.
   PubMedGoogle Scholar
• Harinasuta C, Wasi C, Vithanomsat S (1984). The effect of interferon on Japanese encephalitis virus in vitro. South-east Asian J Trop Med Pub Health 15: 564–568.
   PubMedGoogle Scholar
• Hasegawa H, Yoshida M, Shiosaka T, Fujita S, Kobayashi Y (1992). Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191: 158–165.
   Google Scholar
• Heinz FX, Allison SL (2001). The machinery for flavivirus fusion with host cell membranes. Curr Opin Microbic)] 4: 450–455.
   Google Scholar
• Hennessy S, Zhengle L, Tsai TF, Strom BL, Chao-Min W, Hui-Lian L, Tai-Xiang W, Hong-Ji Y, Qi-Mau L, Karabatsos N, Bilker WB, Halstead SB (1996). Effective-ness of live-attenuated Japanese encephalitis vaccine (5A14-14-2): a case control study. Lancet 347: 1583–1586.
   PubMed Web of Science ®Google Scholar
• Holzmann H, Heinz FX, Mandl C, Guirakhoo F, Kunz C (1990). A single amino acid substitution in envelope pro-tein of tick borne encephalitis virus leads to attenuation in the mouse model. J Gen Virol 64: 5156–5159.
   Google Scholar
• Huang CH, Wong C (1963). Relation of the peripheral mul-tiplication of Japanese B encephalitis virus to the patho-genesis of the infection in mice. Acta Virol 7: 322–330.
   Google Scholar
• Jan JT, Chen BH, Ma SH, Liu CI, Tsai HP, Wu HC, Jiang SY, Yang KD, Shaio MF (2000). Potential dengue virus-triggered apoptotic pathway in human neuroblastomacells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J Virol 74: 8680–8691.
   PubMed Web of Science ®Google Scholar
• Jan LR, Chen KL, Lu CF, Wu YC, Homg CB (1996). Com-plete nucleotide sequence of the genome of Japanese encephalitis virus ling strain: the presence of a 25-nucleotide deletion in the 3'-nontranslated region. Am J Trop Med Hyg 55: 603–609.
   Google Scholar
• Johnson RT, Burke DS, Elwell M, Leake CJ, A N, Hoke CH, Lorsomrudee W (1985). Japanese encephalitis: i=uno-cytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18: 567–573.
   PubMed Web of Science ®Google Scholar
• Johnston LJ, Halliday GM, King NJ (2000). Langerhans cells migrate to local lymph nodes following cutaneous infec-tion with an arbovirus. J Invest Dermatol 114: 560–568.
   PubMed Web of Science ®Google Scholar
• Kaiser R (1995). Tick-borne encephalitis in southern Germany. Lancet 345: 463.
   PubMed Web of Science ®Google Scholar
• Kalita J, Misra UK (2000). Markedly severe dystonia in Japanese encephalitis. MovDisord 15: 1168–1172.
   PubMed Web of Science ®Google Scholar
• Kanesa-thasan N, Smucny JJ, Hoke CH, Marks DH, Konishi E, Kurane I, Tang DB, Vaughn DW, Mason PW, Shope RE (2000). Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombi-nant Japanese encephalitis virus-poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine 19: 483–491.
   PubMed Web of Science ®Google Scholar
• Konishi E, Mason PW, Innis BI, Ennis FA (1995). Japanese encephalitis virus-specific proliferative responses of hu-man peripheral blood T lymphocytes. Am J Trop Med Hyg 53: 278–283.
   PubMedGoogle Scholar
• Kuhn RJ, Zhang W, Rossmann MG, Pletriev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH (2002). Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717–725.
   PubMed Web of Science ®Google Scholar
• Kumar S, Misra UK, Kalita J, Sawani V, Gupta RK, Gujral R (1997). MRI in Japanese encephalitis. Am J Med Sci 39: 180–184.
   Google Scholar
• Kumar R, Mathur A, Kumar A, Sharma S, Chakraborty S, Chaturvedi UC (1990). Clinical features and prognos-tic indicators of Japanese encephalitis in children in Lucknow (India). Indian J Med Res 91: 321–327.
   PubMed Web of Science ®Google Scholar
• Lee E, Lobigs M (2000). Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for gly-cosaminoglycans in entry. J Virol 74: 8867–8875.
   PubMed Web of Science ®Google Scholar
• Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelmann M (2002). A Poliomyelitis-like syndrome from West Nile virus infection. N Engl j Med 347: 1279–1280.
   Google Scholar
• Lescar J, Roussel A, Wien MW, Navaza J, Fuller SD, Wengler G, Rey FA (2001). The Fusion glycoprotein shell of Sem-liki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105: 137–148.
   PubMed Web of Science ®Google Scholar
• Leyssen P, De Clercq E, Neyts J (2000). Perspectives for the treatment of infections with Flaviviridae. Clin Microbic)] Rev 13: 67–82.
   PubMed Web of Science ®Google Scholar
• Liao CL, Lin YL, Wang JJ, Huang YL, Yeh CT, Ma SH, Chen LK (1997). Effect of enforced expression of human bc1-2 on Japanese encephalitis virus induced apoptosis in cul-tured cells. J Virol 71: 5963–5971.
   Google Scholar
• Liao CL, Lin YL, Wu BC, Tsao CH, Wang MC, Liu CI, Huang YL, Chen JH, Wang JP, Chen LK (2001). Salicylates in-hibit flavivirus replication independently of blocking nuclear factor kappa B activation. J Virol 75: 7828–7839.
   Google Scholar
• Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chin SC, Lin YS (2002). Endothelial cell apoptosis induced by antibodies against dengue virus nonstruc-tural protein 1 via production of nitric oxide. J Immunol 169: 657–664.
   PubMedGoogle Scholar
• Ma X, Yu YX, Wang SG (1993). Observations on safety and serological efficacy from a large scale field trial of Japanese encephalitis vaccine. Chin J Biol 6: 188–191.
   Google Scholar
• McMinn PC, Dalgamo L, Weir RC (1996). A comparison of the spread of Murray Valley encephalitis viruses of high or low neuroinvasiveness in the tissues of Swiss mice after peripheral inoculation. Virology 220: 414–423.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J (1997). Movement disorders in Japanese encephalitis. J Neurol 244: 299–303.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J (2001). Seizures in Japanese encephalitis. J Neurol Sci 190: 57–60.
   PubMed Web of Science ®Google Scholar
• Miyake M (1964). The pathology of Japanese encephalitis. WHO Bull 30: 153–160.
   Google Scholar
• Monath TP (2002). Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbic)] Im-munol 267: 105–138.
   PubMed Web of Science ®Google Scholar
• Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F (2002a). Single mutation in the flavivirus envelope protein hinge region increases neu-rovirulence for mice and monkeys but decreases vis-cerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 76: 1932–1943.
   Google Scholar
• Monath TP, Levenbook I, Soike K, Zhang ZX, Ratterree M, Draper K, Barrett AD, Nichols R, Weltzin R, Arroyo J, Guirakhoo F (2000). Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response ef-fectiveness and extended safety testing in rhesus mon-keys. J Virol 74: 1742–1751.
   PubMed Web of Science ®Google Scholar
• Monath TP, McCarthy K, Bedford P, Johnson CT, Nichols R, Yoksan S, Marchesani R, Knauber M, Wells KH, Arroyo J, Guirakhoo F (2002b). Clinical proof of prin-ciple for ChimeriVax: recombinant live, attenuated vac-cines against flavivirus infections. Vaccine 20: 1004–1018.
   PubMed Web of Science ®Google Scholar
• Murgod UA, Muthane UB, Ravi V, Radhesh S, Desai A (2001). Persistent movement disorders following Japanese encephalitis. Neurology 57: 2313–2315.
   Google Scholar
• Ni H, Barrett ADT (1996). Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol 77: 1449–1455.
   PubMed Web of Science ®Google Scholar
• Ni H, Burns NJ, Chang GJ, Zhang MJ, Wills MR, Trent DW, Sanders PG, Barrett AD (1994). Comparison of nu-cleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain 5A14 and its attenuated vaccine derivatives. J Gen Virol 75: 1505–1510.
   PubMed Web of Science ®Google Scholar
• Ni H, Chang GJ, Xie H, Trent DW, Barrett AD (1995). Molec-ular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain 5A14. J Gen Virol 76 ( Pt 2): 409–413.
   Google Scholar
• Parquet MC, Kumatori A, Hasebe F, Mathenge EG, Morita K (2002). St. Louis encephalitis virus induced pathology in cultured cells. Arch Virol 147: 1105–1119.
   Google Scholar
• Pyke AT, Williams DT, Nisbet DJ, van den Hurk AF, Taylor CT, Johansen CA, Macdonald J, Hall RA, Simmons RJ,
   Google Scholar
• Mason RJ, Lee JM, Ritchie SA, Smith GA, Mackenzie JS (2001). The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg 65: 747–753.
   Google Scholar
• Ramakrishna C, Desai A, Shankar SK, Chandramuki A, Ravi V (1999). Oral immunisation of mice with live Japanese encephalitis virus induces a protective im-mune response. Vaccine 17: 3102–3108.
   Google Scholar
• Raung SL, Kuo MD, Wang YM, Chen CJ (2001). Role of reactive oxygen intermediates in Japanese encephalitis virus infection in murine neuroblastoma cells. Neurosci Lett 315: 9–12.
   Google Scholar
• Rey FA, Heinz FX, Mandl C, Kunz C, Harrison C (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375: 291–298.
   PubMed Web of Science ®Google Scholar
• Roehrig JT, Hunt AR, Johnson AL Hawkes RA (1989). Syn-thetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley en-cephalitis virus elicit antiviral antibody. Virology 171: 49–60.
   Google Scholar
• Shlim DR, Solomon T (2002). Japanese encephalitis vac-cine for travelers: exploring the limits of risk. Clin Infect Dis 35: 183–188.
   PubMed Web of Science ®Google Scholar
• Solomon T (2000). Japanese encephalitis. In: Neurobase. Gilman S, Goldstein GW, Waxman SG, (eds). San Diego: Medlink Publishing. Available on CD-ROM.
   Google Scholar
• Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT (2000a). Japanese encephalitis. J Neurol Neurosurg Psychiatry 68: 405–415.
   PubMed Web of Science ®Google Scholar
• Solomon T, Dung NM, Kneen R, Thao LT, Gainsborough M, Nisalak A, Day NP, Kirkham FJ, Vaughn DW, Smith S, White NJ (2002a). Seizures and raised intracranial pres-sure in Vietnamese patients with Japanese encephalitis. Brain 125: 1084–1093.
   PubMed Web of Science ®Google Scholar
• Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LTT, Raengsakulrach B, Day NPJ, Farrar J, Myint KSA, Nisalak A, White NJ (2000b). Neurological manifestations of dengue infection. Lancet 355: 1053–1059.
   PubMed Web of Science ®Google Scholar
• Solomon T, Dung NM, Wills B, Kneen R, Gainsborough M, Diet TV, Thuy TTN, Loan HT, Khanh VC, Vaughn DW, White NJ, Farrar JJ (2002b). A double-blind placebo-controlled trial of interferon alpha in Japanese en-cephalitis. Lancet 361: 821–826.
   Google Scholar
• Solomon T, Kneen R, Dung NM, Khanh VC, Thuy TTN, Ha DQ, Day NPJ, Nisalak A, Vaughn DW, White NJ (1998). Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 351: 1094–1097.
   PubMed Web of Science ®Google Scholar
• Solomon T, Vaughn DW (2002). Clinical features and patho-physiology of Japanese encephalitis and West Nile virus infections. In: Current topics in microbiology and im-munology: Japanese encephalitis and West Nile virus infections. Mackenzie JS, Barrett AD, Deubel V (eds). Berlin: Springer-Verlag, pp 171–194.
   Google Scholar
• Stadler K, Allison SL, Schalich J, Heinz FX (1997). Prote-olytic activation of tick-borne encephalitis virus by fu-rin. J Virol 71: 8475–8481.
   PubMed Web of Science ®Google Scholar
• Su CM, Liao CL, Lee YL, Lin YL (2001). Highly sulfated forms of heparin sulfate are involved in japanese en-cephalitis virus infection. Virology 286: 206–215.
   PubMed Web of Science ®Google Scholar
• Tsai TF (2000). New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vac-cine 18 (Suppl 2): 1–25.
   Google Scholar
• Uchil PD, Satchidanandam V (2001). Phylogenetic analy-sis of Japanese encephalitis virus: envelope gene basedanalysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg 65: 242–251.
   PubMed Web of Science ®Google Scholar
• Vaughn DW, Hoke CH (1992). The epidemiology of Japanese encephalitis: prospects for prevention. Epi-demiol Rev 14: 197–221.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS (2000). Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6: 816–820.
   Google Scholar
• Xiao SY, Zhang H, Guzman H, Tesh RB (2001). Experimen-tal yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology. J Infect Dis 183: 1437–1444.
   Google Scholar
• Xin YY, Ming ZG, Peng GY, Jian A, Min LH (1988). Safety of a live-attenuated Japanese encephalitis virus vaccine (5A14-14-2) for children. Am J Trop Med Hyg 39: 214–217.
   PubMed Web of Science ®Google Scholar